Alternatively, tyrosine kinase inhibitors and TGF-β blockers can be used to inhibit the immunosuppressive function of TANs, achieving enhanced immune cell function and inhibiting tumor growth [131, 132]. Here, TGFB1 is linked to neoplasm.